ArticleExperimental and therapeutic medicine2013

Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease.

Weisong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.